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The effectiveness of a genetics-based public health screening programs depend on the successful recruitment of
subjects who qualify for intensified screening by virtue of a positive genetic test. Herein we compare the effectiveness
of a mailed invitation and follow-up phone call for non-responding subjects and an initial invitation by telephone
addressed to male BRCA1 mutation carriers for prostate screening.
The final participation rate was 75% (42 of 56) for men who were initially contacted by mail (and follow-up phone
call) and 81% (30 of 37) for men who were initially contacted by telephone. Among the men who were initially
contacted by mail, it was necessary to telephone 54% of these patients (30 of 56).
After a calculation of the cost-effectiveness related to these results, we conclude that if the costs of the phone
call were to exceed the costs of the letter by 2.5 times or more, then savings would be arranged by initiating
contact with a mailed invitation.Introduction
Mutations in BRCA1 and BRCA2 confer high risks of
breast and ovarian cancer in women [1-4]. Men who
carry a mutation in these genes are at increased risk of
prostate cancer [5-7] Extensive population screenings
for prostate cancer are of limited cost-effectiveness,
however if they are addressed to high risk groups of
patients only, the cost-effectiveness seem to be satisfactory,
and BRCA1 and BRCA2 carriers may benefit from
cancer surveillance using PSA and rectal examination.
The success of a genetic-based public health screening
program depends on the efficient recruitment of subjects
who qualify for intensified screening by virtue of a positive
genetic test. There are several methods by which health-
care professionals might encourage patients to participate
in enhanced screening programs. The passive approach
depends on public awareness the potential participant is
made aware of (that screening is available) and approaches
the screening center on their own volition or upon
the recommendation of their physician; in this case,
recruitment is enhanced by media coverage, as well* Correspondence: jgron@pum.edu.pl
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reproduction in any medium, provided the oras by advertisement [8]. Two active recruitment methods
include mailing a letter of invitation to the subject or a
phone call from a trained staff member [9,10]. It has
been shown that the mailed invitation approach is less
expensive than direct active recruitment (telephone
call), however it may be less effective [11,12] and may
not be cost-effective in terms of the actual number of
subjects recruited successfully. In some jurisdictions,
recruiters will initially use a mailed approach and follow
this up with a phone call to those subjects who did not
respond to the initial mailed request. An alternative for
mail invitation would be an email invitation, however
nowadays it is of limited use if the program is directed
towards older patients, who do not use the internet
frequently, or inhabitants of rural areas with not satisfactory
access to internet [13].
To our knowledge, there are no studies which evaluate
the effectiveness of various recruitment methods for
prostate screening among male BRCA1 mutation carriers.
In this study, we compare the effectiveness of two
approaches: 1) a mailed invitation and follow-up telephone
call for patients who did not respond and 2) an initial
invitation by telephone.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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The Study was performed between November 2008
and March 2009 in the Outpatient Clinic of Genetic
Oncology of Pomeranian Medical University, Szczecin,
Poland. Men aged 40–69, who were residents of the
Western Pomeranian district and who were known to
carry a BRCA1 mutation were eligible to take part in the
Polish Ministry of Science project (PBZ-MNiSW-05/I/
2007/02) on evaluation of the effectiveness of population-
based screening of breast, colon and prostate cancer
through the use of DNA testing for the detection of an
increased genetic predisposition to these cancers [13].
Within this project one of the subject groups were
men, BRCA1 mutation carriers who show increased
risk of prostate cancer. Screening for prostate cancer
was offered within the program and included measurement
of serum PSA (prostate specific antigen) and an urological
prostate examination. Preliminary results of this study
have been published elsewhere [14]. All patients signed
an informed consent for inclusion in the study. The study
was approved by the Ethic Committee of Pomeranian
Medical University.
Men with a known BRCA1 mutation, who had been
previously tested in the genetic clinic were eligible for the
study. 99 male BRCA1 mutation carriers were identified
from the records of the Department of Genetics and
Pathology of PUM. Of these, 93 men were alive and
were eligible to participate in the study. The following
methods were used in order to encourage patients to
participate in program:
a) A mailed invitation was sent to 56 BRCA1
carriers (chosen at random from the 93). The












Figure 1 Flowchart of patient participation.the study, the prostate examination, the
significance and possible benefit of the
examination. The letter included a proposed
time and date of appointment. The invitation
also indicted that changes could be arranged if
the proposed time was inconvenient. In the event
that the subject did not respond to the mailed
invitation, a follow-up phone call was made.
In this case, the study nurse invited the patient
to the program and explained the significance of
examinations, possible benefits and was available
to answer questions. If the subject wished to
participate, an appointment was made.
b) The remaining 37 BRCA1 carriers were
approached directly by a participating study
nurse by telephone. The nurse invited the patient
to the program and explained the significance of
examinations, possible benefits and also answered
questions. If the subject wished to participate, an
appointment was made.
Results
Among the 37 patients selected to be invited by an initial
phone call, all were contacted and 30 (81%) agreed to
participate. Three men refused and four men deferred
participation. Among the 56 subjects who received a
letter of invitation, 26 (46%) agreed to participate and
30 did not respond. A nurse attempted to contact each
of these 30 non-responding subjects but was unable to
contact six of them. Of the 24 men who were contacted
successfully, 16 agreed to participate, 3 refused and 5
deferred participation.
In summary, the ultimate participation rate was 81%
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contacted by mail. Among the men who were contacted
initially by mail, it was necessary to telephone 54% of these
patients (30 of 56). Flowchart of patient participation is
shown on Figure 1.
Discussion
In this study, our overall response rate was high (77%)
indicating a strong interest in prostate cancer screening
among Polish men with a BRCA1 mutation. The response
rate is high as compared to other studies which analyzed
the effectiveness of invitations performed by the same
means [15,16]. In general, men are less likely than woman
to take part in screening programs [17]. However, in
this study all of the participants were carriers of a
BRCA1 mutation and had previously made the decision
to undergo genetic counseling and genetic testing.
Our findings indicate a small advantage of initial
phone call invitations over those made by mail. In the
case of phone calls, 81% of the invited participants
ultimately reported to the study center, whereas the
proportion was 75% for mail invitations followed by a
telephone call for non-responders. The majority of men
who were initially approached by mail also required a
telephone call eventually and we were only able to reduce
the number of telephone calls by 46% by sending an initial
mailed invitation.
Rezner et al. showed that recruitment performed by
direct phone calls as compared to letter invitations may
improve recruitment effectiveness from 9% to 52% [18].
Wong et al. and others studies found that a combination of
several invitation methods can increase uptake, especially,
when mail invitation is followed by a phone invitation
[19-21]. Invitations by telephone are more personal and
may be more understandable to patients. Furthermore,
the time and date of the visit can be adjusted immediately.
The study determined that even for groups of patients
who initially ignored a letter invitation for a screening
program, it is possible to significantly increase the par-
ticipation rate after telephone calls.
Our study did not directly compare the cost-effective-
ness of the two methods. For phone call invitations,
costs include the time spent by staff on performing
calls, as well as the telephone call rates. For mail invitations,
the calculation should include the cost of mail materials,
postal rates and the time spent by staff on preparing
invitations. In this study, using the phone call only
approach, it required a mean of 1.23 phone calls to
obtain one study subject. In the approach with mail
first then phone call it required a mean of 1.33 letters
and 0.71 phone calls per study subject recruited. If the
costs of the letters and phone calls were equal, then the
phone call first method would be more cost-effective.
However, if the cost of the phone call were to exceed thecost of the letter by 2.5 times or more, then savings would
be realized by initiating contact with a mailed invitation.
An alternative to mail invitation is email invitation.
The use of email invitation may significantly reduce the
costs. Email correspondence is much faster and may
include additional tools, like function indicating the
receipt of a message, what would be of value for program
management. This type of invitation is more interactive
and asking possible questions as well as answering is
fast and easy. However, in our study we did not evaluate
this method since the program was directed to significant
proportion of older man, who generally do not use email,
and were frequently coming from rural areas with limited
access to the internet. However, we think that in the near
future email invitation method will not only become an
alternative for mail invitations but that it might replace it.
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